000			02060 a2200601 4500
005			20250512181001.0
264		0	_c19690801
008			196908s 0 0 eng d
022			_a0002-9149
024	7		_a10.1016/0002-9149(69)90389-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aCorday, E
245	0	0	_aPressor agents in cardiogenic shock. _h[electronic resource]
260			_bThe American journal of cardiology _cJun 1969
300			_a900-10 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAnuria _xetiology
650	0	4	_aAortic Valve _xsurgery
650	0	4	_aBlood Flow Velocity
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBlood Viscosity _xdrug effects
650	0	4	_aBlood Volume _xdrug effects
650	0	4	_aCardiac Output _xdrug effects
650	0	4	_aCollateral Circulation
650	0	4	_aCoronary Vessels _xdrug effects
650	0	4	_aDextrans _xtherapeutic use
650	0	4	_aDigitalis Glycosides _xtherapeutic use
650	0	4	_aDogs
650	0	4	_aDopamine _xtherapeutic use
650	0	4	_aEpinephrine _xblood
650	0	4	_aHeart Diseases _xdrug therapy
650	0	4	_aHeart Valve Prosthesis
650	0	4	_aHumans
650	0	4	_aHydrocortisone _xadministration & dosage
650	0	4	_aIschemia
650	0	4	_aLactates _xblood
650	0	4	_aMetaraminol _xtherapeutic use
650	0	4	_aMethylprednisolone _xadministration & dosage
650	0	4	_aNorepinephrine _xblood
650	0	4	_aOxygen Consumption _xdrug effects
650	0	4	_aPhenoxybenzamine _xadministration & dosage
650	0	4	_aShock _xdrug therapy
650	0	4	_aSkin _xblood supply
650	0	4	_aTemperature
650	0	4	_aTime Factors
650	0	4	_aTricuspid Valve _xsurgery
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVasoconstrictor Agents _xtherapeutic use
700	1		_aLillehei, R C
773	0		_tThe American journal of cardiology _gvol. 23 _gno. 6 _gp. 900-10
856	4	0	_uhttps://doi.org/10.1016/0002-9149(69)90389-0 _zAvailable from publisher's website
999			_c5785715 _d5785715